Clene Inc. reports results for the quarter ended September 30 - Earnings Summary

Clene

13/11/2024 14:15

* Clene Inc.  CLNN.OQ  reported a quarterly adjusted loss of
$1.22​​ per share for the quarter ended September 30, lower than
the same quarter last year, when the company reported EPS of -40
cents.  The mean expectation of six analysts for the quarter was
for a loss of $1.32 per share. Wall Street expected results to
range from $-1.51 to $-1.09 per share.
    * Revenue fell 19.4% to $87.00 thousand from a year ago;
analysts
expected $90.00 thousand. 
    * Clene Inc.'s reported EPS for the quarter was a loss of
$1.22​.
    * The company reported a quarterly loss of $7.99 million.
    * Clene Inc. shares had risen by 15.5% this quarter and
lost 10.7%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Clene Inc. is
30.50 
This summary was machine generated from LSEG data November 13 at
02:14 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -1.32          -1.22          Beat
 Jun. 30 2024      -1.49          -1.06          Beat
 Mar. 31 2024      -1.60          -1.80          Missed
 Dec. 31 2023      -1.45          -1.20          Beat